Low White Blood Cells in Breast Cancer: Should You Be Concerned?

A low white blood cell count (especially low neutrophils, called neutropenia) is common during breast cancer treatment, particularly with chemotherapy, and it mainly means your body is temporarily less able to fight infections. ^[1] When counts fall, your care team may adjust timing or doses and may use medications to boost white cells; while this is expected, it’s important to watch closely for infection signs like fever. ^[2]

What “Low White Blood Cells” Means

• White blood cells are part of the immune system; neutrophils are key cells that fight bacterial infections. ^[1]
• Chemotherapy can reduce production of these cells for a short period, increasing infection risk until counts recover. ^[3]
• Many centers consider neutrophils very low when the absolute neutrophil count (ANC) is below about 500 cells/mm³, which is when infection risk is highest. ^[2]

Why It Happens in Breast Cancer Care

• Several breast cancer chemotherapies slow bone marrow production of white cells, leading to predictable dips after treatment. ^[3]
• Counts often drop to their lowest point (“nadir”) roughly 7–14 days after each chemotherapy cycle, then recover before the next cycle. ^{[3] [1]}
• Your team may plan blood tests before each cycle to monitor this pattern. ^[4]

How Serious Is It?

• The main concern is infection; even minor infections can become serious if your white cell count is very low. ^[1]
• Fever (100.4°F or 38.0°C or higher) is usually the first sign of infection during neutropenia and warrants immediate contact with your care team. ^[2]
• If counts are too low, treatment may be delayed until recovery to reduce risk and allow the immune system to rebound. ^{[5] [1]}

Common Timing and What to Expect

• Expect the lowest white cell counts about 7–14 days after chemotherapy; your team can tell you your likely nadir based on your regimen. ^{[6] [3]}
• Many people receive preventive or supportive medications to raise counts (growth factors, such as filgrastim or pegfilgrastim) between cycles. ^{[5] [7]}
• Blood counts typically recover on their own over time; schedules may be adjusted if you develop low counts or fever. ^{[5] [1]}

How Your Team Manages It

• Growth factor injections (G‑CSF) can help shorten the duration of neutropenia and reduce infection risk or treatment delays. ^{[7] [8]}
• Clinics follow pre-treatment ANC thresholds; for example, treatment may be delayed when ANC is below certain levels to protect you. ^[9]
• Routine labs before each cycle guide safe timing and dose decisions. ^[4]

Safety Tips to Lower Infection Risk

• Monitor temperature; call promptly for fever ≥100.4°F (38.0°C), chills, or new cough. ^[2]
• Practice strict hand hygiene and avoid close contact with sick individuals, especially during the nadir days after chemo. ^[10]
• Keep mouth care gentle, and watch for mouth sores, urinary burning, or skin redness, all of which can be early infection clues. ^[11]
• Follow any instructions if you are prescribed growth factor injections or device-based support to maintain counts. ^[12]

When to Seek Care Urgently

• Fever of 100.4°F (38.0°C) or higher, shaking chills, shortness of breath, severe sore throat, painful urination, or any rapidly worsening symptoms need same-day assessment. ^{[2] [1]}
• If you are within the 7–14 day window after chemo and feel unwell, it’s safer to call early rather than wait. ^{[3] [6]}

Bottom Line

• A low white blood cell count during breast cancer treatment is common and expected, and it mainly signals a higher short-term infection risk. ^[3]
• With monitoring, prompt attention to fever, and use of growth factor support when appropriate, most people continue treatment safely. ^{[5] [7]}

---

If you ever develop a fever or feel suddenly unwell between chemo cycles especially 7–14 days after treatment contact your care team right away. ^{[2] [6]}